Menu Close Call 1-800-CEDARS-1 toggle search form Close

Anders H. Berg, MD, PhD

Associate Professor, Pathology

Associate Professor, Biomedical Sciences

Associate Director, Clinical Chemistry

Anders H. Berg, MD, PhD

Send an Email

Pavilion
127 S. San Vincente Blvd.
Room A8110B
Los Angeles, CA
90048

Phone:

310-248-8150

Anders H. Berg, MD, PhD

Associate Professor, Pathology

Associate Professor, Biomedical Sciences

Associate Director, Clinical Chemistry

  • Pathology & Laboratory
  • Clinical Chemistry
  • Clinical Pathology

Chronic Kidney Diseases

Diabetes Mellitus (Type 1 & 2)

Dialysis (Hemodialysis, Peritoneal) - Pediatric

Kidney (Renal) Disorders - Pediatric

Kidney (Renal) Failure

Kidney Transplants

Anders Berg, MD, PhD, is an NIH-funded physician-scientist with a focus on focus on the metabolic pathophysiology and diagnostic challenges of kidney disease, diabetes mellitus, and their complications. His laboratory is engaged in translational research, using animal models and human clinical correlation studies to understand the pathophysiology of uremia, and developing mass spectrometric diagnostic tests for kidney disease, diabetes mellitus, and vitamin D deficiency.

View NIH Biographical Sketch as a PDF

  • Doctorate: Albert Einstein College of Medicine, 2004
  • Medical School: Albert Einstein College of Medicine, 2004
  • Residency: Brigham and Women's Hospital, 2007

View CV as a PDF

  • Member, Nominating and awards committee, Academy of Clinical Laboratory Physicians and Scientists, 2018-present
  • Reviewer, NIDDK Special Emphasis Panel SRG ZDK1 GRB-S, 2015
  • Harold Dvorak Young Investigator Award, Beth Israel Deaconess Medical Center Chief Academic Officer Pilot Grant Program, 2015
  • Reviewer, Research Grant Review Committee, American Diabetes Association, 2011-2018

Click here for a list of peer-reviewed publications.

  • Berg AH (corresponding author), Drechsler C, Wenger J, Buccafusca R, Hod T, Kalim S, Ramma W, Parikh SM, Steen H, Friedman DJ, Danziger J, Wanner C, Thadhani R, Karumanchi SA. Carbamylation of serum albumin as a risk factor for mortality in patients with kidney failure. Sci Transl Med. 2013 Mar 6;5(175):175ra29. PMID: 23467560. PMCID: PMC3697767.
  • Drechsler C, Kalim S, Wenger J, Suntharalingam P, Hod T, Thadhani R, Karumanchi SA, Wanner C, Berg AH. Protein carbamylation is associated with heart failure and mortality in diabetic patients with end stage kidney disease. Kidney Int. 2015 Feb 11. doi: 10.1038/ki.2014.429. PMCID: PMC4449819.
  • Kalim S, Trottier CA, Wenger JB, Wibecan J, Ahmed R, Ankers E, Karumanchi SA, Thadhani R, Berg AH. Longitudinal Changes in Protein Carbamylation and Mortality Risk after Initiation of Hemodialysis. Clin J Am Soc Nephrol. 2016. Epub 2016/07/23. doi: 10.2215/CJN.02390316. PubMed PMCID: PMC5753089.

English

Make an Appointment

Call

1-800-CEDARS-1

(1-800-233-2771)

Available 24 Hours A Day

or

Many of the physicians who have medical staff privileges to practice medicine at Cedars-Sinai Medical Center are independent physicians, and not employees or agents of the hospital. These independent physicians bill separately for their services. You should contact your physician to determine their status and billing practices.